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Abstract The hydrophobicity (H), hydrophobic moment (|i) and 
the angle subtended by the positively charged helix face (<t>) of a 
set of model and magainin 2 amide peptides with conserved 
charge and helix propensity have been shown to be effective 
modulators of antibacterial and haemolytic activity. Except 
peptides of low hydrophobicity which are inactive, changing the 
parameters has little influence on the activity against Gram-
negative bacteria, thus revealing the dominance of electrostatic 
interactions for the effect. However, the increase of H, |i and <5> 
substantially enhances haemolytic and Gram-positive antibacter-
ial activity and is related to a reduction of peptide specificity for 
Gram-negative bacteria. 
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1. Introduction 
During the last decade a multitude of host defence peptides 
have been found in a wide range of species (for review, see [1-
3]). These peptides can broadly be classified into cytolytic 
peptides, active against prokaryotic as well as eukaryotic cells 
such as melittin and antimicrobial peptides such as the mag-
ainins. Both classes of peptides exert their activity by enhanc-
ing the permeability of the cell membrane which has been 
suggested to be caused by the formation of ion channels or 
a global disturbance of the lipid bilayer [4,3]. Because of their 
putative clinical relevance, structure-function correlation of 
membrane active peptides has been the subject of extensive 
investigations [5-9]. Recent studies have correlated the specific 
antimicrobial activity of the magainins with the high content 
of negatively charged phospholipids, the inside negative trans-
membrane potential and the low cholesterol content of bacte-
rial cell membranes [10-12]. However, despite advances in 
identifying activity modulating membrane properties, the 
structural differences between antimicrobial and lytic peptides 
are subtle. Generally, membrane active peptides are able to 
form an amphipathic secondary structure in a membrane en-
vironment. Significantly, in addition to assuming mostly an a-
helical conformation the antibacterial peptides are cationic in 
nature. The positive charge was found to drive peptide bind-
ing at negatively charged lipid bilayers [13-15] and can also be 
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expected to facilitate peptide attachment at the negatively 
charged bacterial surface [16]. 
Several attempts have been described to improve antimicro-
bial activity and enhance selectivity by increasing the positive 
charge and/or helicity [17,18,5,19]. However, often enhanced 
activity was found to be connected with reduced selectivity. 
More recent investigations using a cationic amphipathic mod-
el peptide [14] and paradaxin analogs [20] revealed that hel-
icity is less crucial for the antibacterial effect. However, the 
correlation of helicity of lipid membrane bound peptides with 
haemolytic activity supported the significant role of the am-
phipathic helix for the effect on red blood cells. The investi-
gations led to the conclusion that peptide modifications that 
enhance the disturbance of the negatively charged phospholi-
pid headgroups should increase antibacterial activity whereas 
modifications compatible with an increase in hydrophobic 
peptide-membrane interactions should enhance the haemo-
lytic effect. Actually, changes in the total hydrophobicity of 
the model peptide have been found to correlate with the abil-
ity to permeabilize electrically neutral model membranes 
whereas the influence on activity observed at negatively 
charged lipid bilayers could be neglected [14]. Additionally, 
studies with magainin analogs revealed that the selectivity 
for negatively charged membranes substantially decreases 
with increasing peptide hydrophobicity [21]. These results 
and recent investigations of Maloy et al. [5] and Zhong et 
al. [6] prompted us to examine the effect of hydrophobicity 
(H), the hydrophobic moment (|x) and the angle (<D) sub-
tended by the cationic helix domain on membrane activity 
and selectivity. Using a set of potentially helical model pep-
tides and magainin 2 amide (M2a) analogs, these structural 
properties were related in this study to antibacterial and hae-
molytic activity. 
2. Materials and methods 
Model peptides and M2a analogs (Table 1) were synthesized auto-
matically by the solid-phase method using standard Fmoc chemistry 
in the continuous flow mode [22]. The peptides were purified by prep-
arative high performance liquid chromatography (HPLC) to give final 
products more than 95% pure by RP-HPLC analysis and character-
ized by quantitative amino acid analysis. Trifluoroethanol (TFE) was 
obtained from Aldrich-Chemie (Steinheim, Germany) and the other 
chemicals were from Merck (Darmstadt, Germany). 
Peptide hydrophobicity (H) and the hydrophobic moment (u) for 
an ideal helix were calculated using the Eisenberg's scale for hydro-
phobicity and moment method [23]. 
Circular dichroism (CD) measurements of 10~5 M peptide solutions 
in TFE/buffer (10 mM Tris(hydroxymethyl)aminomethane, 154 mM 
NaF (pH 7.4), 1:1 (v/v)) were carried out on a J720 spectrometer 
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(Jasco, Japan) between 185 and 260 nm at room temperature. The 
helicity was determined from the mean residue ellipticity at 222 nm 
according to Chen et al. [24]. The error in the helicity was 5%. 
The haemolytic activity of the peptides was determined using hu-
man red blood cells as described previously [14], In brief, 150 iti of cell 
suspension containing 1.2xl09 cells/ml and varying amounts of pep-
tide stock solution (concentration usually 10 - 4 mol/1 in Tris buffer) 
and buffer were pipetted into Eppendorf tubes to give a final volume 
of 1000 ul. The suspensions containing 1.8 XlO8 cells/ml were incu-
bated for 30 min at 37°C. After cooling in ice water and centrifuga-
tion at 2000 X g for 5 min, 200 iti of supernatant was combined with 
1800 ul of 0.5% NH4OH and the optical density was measured at 540 
nm. Peptide concentrations causing 50% haemolysis (EC50) were de-
rived from the dose-response curves. Values determined in repeat 
experiments differed by less than 5%. 
Antimicrobial susceptibility testing was performed using a modifi-
cation of the National Committee for Clinical Laboratory Standards 
(NCCLS) microdilution broth assay [25]. Mueller Hinton broth (BBL, 
CockeysviUe, MD) was used for diluting the peptide stock solution 
and the bacterial inoculum. The inoculum was prepared from mid 
logarithmic phase cultures at an approximate concentration of 
1X 106 CFUs/ml and 100 ul of this solution was added to 100 fxl of 
the peptide dilution in the well. The final concentration of peptide 
solution ranged from 0.25 to 256 ug/ml in 2-fold dilutions. The final 
concentration of bacteria in the wells was 1 X 105 to 5 X 105 CFUs/ml. 
Peptides were tested in duplicates. In addition to the test peptide, 
three standard peptides and a non-treated growth control were in-
cluded to validate the assay. The microtiter plates were incubated 
overnight at 37°C and the absorbance was read at 630 nm. The Min-
imal Inhibition Concentration (MIC) is defined as the lowest concen-
tration of peptide that completely inhibits growth of the test organ-
ism. 
3. Results 
The 18-residue model peptide (KLA1) and M2a consisting 
of 23 amino acid residues used as basis for structural modifi-
cations exhibit significant differences in their structural motifs 
(Fig. 1, Tables 1 and 2). While KLA1 contains five lysine 
residues causing a net positive charge of +6, M2a bears four 
lysine, one histidine and one glutamic acid residue resulting in 
a net positive charge of about +4 at physiological pH. The H 
and [i of the model peptide KLA1 are comparably high 
(—0.025 and 0.33, respectively) and the angle subtended by 
the lysine residues (<£>) is low (80°), while H and u, of M2a are 
lower (—0.0357 and 0.238, respectively) and <B is significantly 
larger (120°). By minimal amino acid substitution (Table 1) 
based on the hydrophobicity scale of Eisenberg [22] and the 
conformational parameters for a-helical residues of Chou and 
Fasman [26] one specific peptide property such as hydropho-
bicity, hydrophobic moment and angle of the positively 
charged face of the amphipathic peptide helix was modified 
while conserving the other structural features (Table 2). The 
peptide charge was always kept constant and the helix pro-
pensity was retained (Table 2) as probed by CD measure-
ments in structure inducing buffer/TFE mixture. 
KLA1 displays both high antibacterial and haemolytic ac-
tivity (Table 2). Reduction of H from -0.025 to -0.056 
(KLA2) only slightly decreases the MIC against Gram-nega-
tive bacteria but causes substantial loss of activity against S. 
aureus and erythrocytes. Very low hydrophobicity (KLA3) 
abolishes activity. Changes of the hydrophobic moment are 
most effective at low peptide hydrophobicity. Thus, reduction 
of tt by 0.045 (KLA1 vs. KLA11) or increase of it by 0.122 
(KLA1 vs. KLA7) have little influence on activity on bacteria 
and only the last modification (A|j, = 0.122) causes a 10-fold 
increase in haemolytic activity. A comparably slight increase 
in it by 0.062 of the more hydrophilic peptide KLA2 (KLA2 
vs. KLA12) also scarcely influences the MIC against Gram-
negative bacteria but enhances the activity against S. aureus 
and the haemolytic effect by a factor of about 30 and 10, 
respectively. The reduction of activity caused by decreasing 
H can be compensated for by an increase of \i (compare 
KLA1, KLA2 and KLA12). The angle subtended by the cat-
ionic residues of the amphipathic peptide helix exhibits little 
influence on the cytotoxic activity against bacteria. However, 
the haemolytic activity significantly increases if O was greater 
than 80° (KLA9, KLA10, KLA8,). The effect is not caused by 
the change in \i (KLA1 vs. KLA9) as the comparison of the 
results with KLA1 and KLA11 reveals. 
The effects of H, u, and <D on activity modification are 
confirmed by M2a peptides. The high MIC and EC50 values 
for M2a compared to KLA1 confirm the importance of total 
hydrophobicity and hydrophobic moment to the biological 
effect. The difference in activity is most pronounced on S. 
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210 M. Dathe et al.lFEBS Letters 403 (1997) 208-212 
Fig. 1. Helical wheel projection of KLA1 and M2a. 
aureus and on red blood cells where the MIC and EC50 values 
of the two peptides differ by a factor of about 40. The increase 
of H and |i for M2a enhances antibacterial as well as haemo-
lytic activity. A higher hydrophobic moment (I6RnR1 4W1 6-
M2a) even restores gone bioactivity to the most hydrophilic, 
biologically inactive peptide L2RnA20-M2a. Changing the po-
lar face of the magainin helix from 100° to 140° produced the 
most pronounced effect on the antibacterial activity, with the 
maximum activity observed for the 140-M2a analog. 
With respect to selectivity of KLA and magainin peptides 
the investigation revealed the following result : The differences 
between MIC and EC50 values for KLA peptides decrease 
with increasing H, |j, and <I>. Reduction of the hydrophobicity 
of KLA1 (KLA1 vs. KLA2) increases the EC50 of haemolytic 
activity by a factor of 10 and an increase in the hydrophobic 
moment of KLA1 and KLA2 or an angle of the cationic face 
larger than 80° cause a 10-fold decrease of the EC50 values 
while the activity against E. coli and P. aeruginosa remains 
almost unchanged. Thus, low peptide hydrophobicity enhan-
ces Gram-negative bacterial specificity and large |x and <E> 
Table 2 
Structural parameters and antibacterial and haemolytic activity of KLA and M2a peptides 
Variable 
H 
R 
H 
t> 
H 
H 
V 
4> 
Peptide 
KLA3 
KLA2 
KLA1 
KLA2 
KLA12 
KLA11 
KLA1 
KLA7 
KLA1 
KLA9 
KLA10 
KLA8 
L2R11A20-M2a 
M2a 
I6L15-M2a 
I6A8L15I17-M2a 
L2R11A20-M2a 
I 6 R n R i 4 W i 6 . M 2 a 
M2a 
r3v9W12T15I17-
M2a 
100-M2a 
W16-M2a 
140-M2a 
160-M2a 
H 
-0.087 
-0.056 
-0.025 
-0.056 
-0.056 
-0.026 
-0.025 
-0.026 
-0.025 
-0.025 
-0.025 
-0.025 
-0.0957 
-0.0357 
-0.0148 
0.0157 
-0.0957 
-0.0983 
-0.0357 
-0.0352 
-0.045 
-0.046 
-0.049 
-0.047 
li 
0.329 
0.329 
0.329 
0.329 
0.391 
0.284 
0.329 
0.451 
0.329 
0.295 
0.299 
0.291 
0.287 
0.286 
0.284 
0.280 
0.287 
0.332 
0.286 
0.317 
0.288 
0.288 
0.288 
0.288 
4»(°) 
80 
80 
80 
80 
80 
80 
80 
80 
80 
120 
140 
180 
120 
120 
120 
120 
120 
120 
120 
120 
100 
120 
140 
160 
a (%) 
(50% TFE) 
59 
68 
73 
68 
67 
69 
73 
70 
73 
55 
62 
62 
45 
57 
57 
61 
45 
52 
57 
64 
48 
57 
75 
54 
Antibacterial 
E. coli 
MIC (11M) 
91 
5.5-11 
2.6-5.2 
5.5-11 
6 
5.3 
2.7-5.4 
5.6 
2.6-5.2 
6.2 
6.1 
2.9-5.8 
75 
40 
19-38 
2.4 
75 
37.5 
40 
2.3 
75 
40 
13 
19 
activity 
P. aeruginosa 
MIC (11M) 
>91 
45 
10.4-20.8 
44 
24 
21.2 
10.4-20.8 
11.2 
10.4-20.8 
12.4 
12.2 
5.8 
>75 
80 
76 
19-28 
>75 
75 
80 
18 
>75 
80 
13 
19 
S. aureus 
MIC (uM) 
>91 
45 
1.3-2.6 
44 
1.5 
5.3 
1.3-2.6 
1.4 
1.3-2.6 
1.6 
1.5 
3.0 
>75 
>80 
38 
9.6 
>75 
>75 
>80 
18 
>75 
>80 
13 
76 
Haemolytic activity 
EC50 (nM) 
>200 
107 
11 
107 
10 
10 
11 
1.8 
11 
1.7 
2.0 
2.5 
>1000 
428 
260 
32 
>1000 
303 
428 
56 
700 
509 
35 
82 
Peptide hydrophobicity per residue (H) was calculated from the sum of hydrophobicity values of the individual residues and the hydrophobic 
moment (u) for an ideal helix was determined as described by Eisenberg [22]. 
<J> represents the angle subtended by the cationic residues on the ideal peptide helix. 
The helicity (a) in Tris buffer/TFE= 1:1 (v/v) was determined from the molar ellipticity at 222 nm using the equation of Chen et al. [23]. 
The minimal inhibition concentration (MIC) of bacterial growth and the half maximal concentration (EC50) of peptide induced haemolysis were 
determined as described. 
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reduce selectivity. The most selective magainin peptide seems 
to be M2a itself, however, the overall antibacterial activity is 
poor. 
4. Discussion 
Our investigations reveal that hydrophobicity, the hydro-
phobic moment and the angle subtended by the positively 
charged helix face are effective modulators of antibacterial 
and haemolytic activity and useful variables to modify mem-
brane selectivity of cationic, potentially helical, membrane ac-
tive peptides. 
Although there is consensus that membrane active peptides 
exert their activity in a two-step process by (i) binding and (ii) 
disturbance of the lipid matrix, the mechanism of antibiotic 
and cell lytic activity is a matter of debate. The absence of 
detailed structural information for the peptides at the site of 
action and the complexity of the structure of biological mem-
branes seriously hamper the interpretation of biological data. 
The membrane of erythrocytes is composed mainly of zwit-
terionic phosphatidylcholine and phosphatidylethanolamine 
with few acidic lipids in the outer leaflet [27]. Thus, electro-
static peptide membrane interactions should be of reduced 
importance and the pronounced differences in the haemolytic 
activity of KLA and magainin peptides cannot be explained 
by the difference is the net positive peptide charges. Hydro-
phobic peptide-membrane interactions should determine the 
haemolytic effect. The direct correlation between haemolytic 
activity and peptide hydrophobicity as well as the hydropho-
bic moment supports a direct peptide interaction with the 
electrically neutral lipid matrix of the blood cells and reflects 
a change in affinity and/or a modified ability to insert into the 
membrane. A similar correlation between peptide hydropho-
bicity and the hydrophobic moment, on the one hand, and 
haemolytic activity has been observed for PGLa (another 
member of the magainin peptide family) and several model 
peptides [28,18]. 
The peptide concentrations necessary to completely inhibit 
bacterial growth are often much lower than the EC50 values 
for erythrocyte lysis. But interestingly, activity changes in-
duced in the Gram-positive bacteria S. aureus, mostly parallel 
haemolytic activity leading to the suggestion that hydrophobic 
peptide-membrane interactions play a decisive role. However, 
in contrast to red blood cells, Gram-positive bacterial mem-
branes contain negatively charged compounds such as teichoic 
and teichuroic acids and the carboxyl groups of amino acids 
found in the peptidoglycan layer [29]. Thus, the low MIC 
values against S. aureus compared to EC50 could be explained 
in part by the demonstrated increased peptide affinity to neg-
atively charged surfaces [14,15]. The differences in the activity 
of KLA and magainin peptides can be related to the different 
cationic charges of the two sets of peptides (+6 and +4, re-
spectively) as found also for other model peptides and anti-
microbial peptide analogs [17,5]. 
Gram-negative bacterial envelops are complex structures 
composed of an inner membrane which is comparable to 
mammalian cells [30] and an outer membrane with a high 
degree of negatively charged lipopolysaccharides located on 
the exterior surface of the outer membrane. To reach the 
target, the cationic peptides have to overcome the barrier of 
the Gram-negative outer membrane. This first step, suggested 
to be a reversible outer membrane permeabilization, should be 
facilitated by the high membrane bound concentration of the 
cationic peptides. The second step is suggested to be irrever-
sible inner membrane damage leading to cell death [31]. At 
this membrane, hydrophobic interactions become dominant 
and although the peptide affinity is low, molecules that over-
come the outer membrane may disturb the target membrane 
most effectively with high peptide hydrophobicity, hydropho-
bic moment and high angle of the charged domain. A com-
parison of the ability of the peptides to lyse red blood cells 
and to inhibit the growth of Gram-negative bacteria reveals 
that changes in structural properties generally more affect the 
haemolytic than the antibacterial activity. Obviously, electro-
static interactions play the decisive role for the overall effect 
on Gram-negative bacteria. The change in the dominance of 
electrostatic and hydrophobic peptide membrane interactions 
might also provide an explanation for the prokaryotic specif-
icity of peptides such as magainin while other cationic pep-
tides such as melittin bearing a large hydrophobic sequence 
region are effective against bacteria as well as mammalian 
cells. 
Alterations of structural features that modify peptide activ-
ity against red blood cells but have less influence on the anti-
bacterial activity lead consequently to variations in selectivity. 
Some selectivity for Gram-negative bacteria is exhibited by 
peptides of moderate hydrophobicity (—0.025 > H>—0.056) 
which have additionally a low hydrophobic moment and 
low angle subtended by the charged residues (see KLA2, 
M2a, 100-M2a). However, in comparison with changes in 
the selectivity for bacteria found with an increase in the pos-
itive peptide charge [5], the hydrophobic parameters seem to 
play a reduced role for specificity. Additionally, these modifi-
cations causing antibacterial specificity often also reduce anti-
bacterial activity as seen with M2a peptides. 
The two sets of peptides with modified hydrophobic motifs 
were designed using oc-helical parameters for amino acid res-
idues of Chou and Fasman [26]. Although the TFE/buffer 
system has been found to be less suitable to describe the 
membrane bound structure of peptides [15] and the helix pro-
pensity of individual amino acid residues in membrane envi-
ronment can be quite different from that in solution [32] and 
dependent on hydrophobicity [33] we used the helicity under 
structure inducing TFE conditions to characterize the peptides 
by evaluating their potential to assume helix conformation 
[34]. The determination of the conformation of membrane 
bound peptides is crucial, especially with peptides exhibiting 
low affinity to the membrane. In the case of incomplete bind-
ing, the CD effects observed in the presence of model mem-
branes always reflect the properties of a mixture of bound and 
free peptides as documented for KLA and M2a peptides 
[14,15]. Our results show that the modifications in the sequen-
ces had little influence on the helical propensity. While peptide 
hydrophobicity is independent of helicity, deviations from the 
ideal oc-helix change the theoretical hydrophobic moment and 
the angle subtended by the cationic helix domain, and pep-
tides with a low hydrophobic moment were found to develop 
reduced helicity [7]. Thus, the low activity of the most hydro-
philic KLA and M2a analogs which exhibit a comparably low 
helicity (KLA3, 59%; and L2RnA20-M2a, 45%) and the com-
parably high activity of 140-M2a with 75% helical content 
might be caused by a change in the actual hydrophobic mo-
ment. 
In conclusion, our investigations lead to the suggestion that 
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the haemolytic activity of cationic, potentially helical peptides 
is substantially modulated by the investigated parameters and 
increases with hydrophobicity, the hydrophobic moment and 
the angle of the positively charge helix face. An antibacterial 
selectivity seems to be reached with peptides of moderate hy-
drophobicity by reducing the hydrophobic moment and keep-
ing the angle subtended by cationic residues small. Fur ther 
investigations to qualitatively and quantitatively describe the 
structure-activity relation of the peptides on the level of model 
membranes are in progress. 
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